Janney Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Janney Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,018	Closed	-$409K	–	208
2020 Q3	$409K	Sell	3,018 -156,648	-98%	-$21.3M	0.03%	149
2020 Q2	$21.8M	Sell	159,666 -14,582	-8%	-$1.86M	1.51%	14
2020 Q1	$18.8M	Sell	174,248 -17,255	-9%	-$1.99M	1.44%	17
2019 Q4	$23.1M	Buy	+191,503	New	+$21.4M	1.25%	21
2017 Q4	–	Sell	-317,385	Closed	-$35.3M	–	230
2017 Q3	$35.3M	Sell	317,385 -6,390	-2%	-$683K	1.52%	12
2017 Q2	$33.5M	Sell	323,775 -8,646	-3%	-$852K	1.58%	14
2017 Q1	$32.5M	Buy	332,421 +85,509	+35%	+$8.19M	1.5%	14
2016 Q4	$21.8M	Sell	246,912 -11,958	-5%	-$1.09M	1%	27
2016 Q3	$25M	Buy	+258,870	New	+$24.6M	1.13%	26

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Janney Capital Management's IBB Position: Q4 2020 in Review

Janney Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 3,018 shares — an estimated $409K sold.

Janney Capital Management first reported a position in IBB in Q3 2016 and held it in 9 quarters. The position peaked at $35.3M in Q3 2017. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Janney Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Janney Capital Management sold 3,018 iShares Biotechnology ETF shares in Q4 2020, an estimated $409K.
Janney Capital Management first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 9 quarters.
Janney Capital Management's iShares Biotechnology ETF position peaked at $35.3M in Q3 2017.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Janney Capital Management's 13F filing for Q4 2020, filed 25 Jan 2021.